Piramal Pharma Limited has issued a Postal Ballot Notice, dated December 8, 2025, seeking shareholder approval for the appointment of Mr. Amit Soni as an Independent Director. The proposed term for Mr. Soni's appointment is five years, commencing from February 9, 2026, to February 8, 2031. The company is utilizing a remote e-voting facility provided by National Securities Depository Limited (NSDL). The remote e-voting period will commence on Thursday, December 18, 2025, at 9:00 a.m. (IST) and conclude on Friday, January 16, 2026, at 5:00 p.m. (IST). Shareholders will cast their votes electronically to approve this special resolution. Mr. Amit Soni brings extensive experience from his roles at CVC Capital and General Atlantic, with a background in technology, financial services, and healthcare investments. His appointment is recommended by the Nomination and Remuneration Committee and the Board of Directors, who believe his skills and experience will add significant value to the company.